Abstract:Rational drug design often starts from specific scaffolds to which side chains/substituents are added or modified due to the large drug-like chemical space available to search for novel drug-like molecules. With the rapid growth of deep learning in drug discovery, a variety of effective approaches have been developed for de novo drug design. In previous work we proposed a method named DrugEx , which can be applied in polypharmacology based on multi-objective deep reinforcement learning. However, the previous version is trained under fixed objectives and does not allow users to input any prior information ( i.e. a desired scaffold). In order to improve the general applicability, we updated DrugEx to design drug molecules based on scaffolds which consist of multiple fragments provided by users. Here, a Transformer model was employed to generate molecular structures. The Transformer is a multi-head self-attention deep learning model containing an encoder to receive scaffolds as input and a decoder to generate molecules as output. In order to deal with the graph representation of molecules a novel positional encoding for each atom and bond based on an adjacency matrix was proposed, extending the architecture of the Transformer. The graph Transformer model contains growing and connecting procedures for molecule generation starting from a given scaffold based on fragments. Moreover, the generator was trained under a reinforcement learning framework to increase the number of desired ligands. As a proof of concept, the method was applied to design ligands for the adenosine A 2A receptor (A 2A AR) and compared with SMILES-based methods. The results show that 100% of the generated molecules are valid and most of them had a high predicted affinity value towards A 2A AR with given scaffolds.

A flexible data-free framework for structure-based de novo drug design with reinforcement learning

Widely Used and Fast De Novo Drug Design by a Protein Sequence-Based Reinforcement Learning Model

DrugEx V3: Scaffold-Constrained Drug Design with Graph Transformer-Based Reinforcement Learning

Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling

Molecular generation strategy and optimization based on A2C reinforcement learning in de novo drug design

Learning to design drug-like molecules in three-dimensional space using deep generative models

De Novo Structure-Based Drug Design Using Deep Learning

De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment

Generation of Rational Drug-Like Molecular Structures Through a Multiple-Objective Reinforcement Learning Framework

Learning on topological surface and geometric structure for 3D molecular generation

Advancing Drug Discovery with Deep Learning: Harnessing Reinforcement Learning and One-Shot Learning for Molecular Design in Low-Data Situations

De novo design of protein target specific scaffold-based Inhibitors via Reinforcement Learning

Structure-based Drug Design Benchmark: Do 3D Methods Really Dominate?

FlexSBDD: Structure-Based Drug Design with Flexible Protein Modeling

Modern hit-finding with structure-guided de novo design: identification of novel nanomolar A2A receptor ligands using reinforcement learning

Enhancing Molecular Design through Graph-based Topological Reinforcement Learning

Geometric Deep Learning for Structure-Based Ligand Design

An Exploration Strategy Improves the Diversity of De Novo Ligands Using Deep Reinforcement Learning: a Case for the Adenosine A2A Receptor

RELATION: A Deep Generative Model for Structure-Based De Novo Drug Design

Molecular Design in Synthetically Accessible Chemical Space via Deep Reinforcement Learning

Structure-based <i>de novo</i> drug design using 3D deep generative models